Established in April 2003, BIONIME is specialized in the business of biotechnology and medical testing. The first product line is the Self Monitoring Blood Glucose (SMBG) System. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patented technology of unique test strip structure. Today, BIONIME employs more than 500 employees and operates 3 subsidiaries in major markets, Europe, America and Asia. Their products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed into the worldwide markets.